SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-068590
Filing Date
2008-11-06
Accepted
2008-11-06 14:52:46
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-25305_110q.htm 10-Q 897109
2 EX-3.5 a08-25305_1ex3d5.htm EX-3.5 165312
3 EX-10.43 a08-25305_1ex10d43.htm EX-10.43 54102
4 EX-31.1 a08-25305_1ex31d1.htm EX-31.1 12066
5 EX-31.2 a08-25305_1ex31d2.htm EX-31.2 12820
6 EX-32 a08-25305_1ex32.htm EX-32 11449
  Complete submission text file 0001104659-08-068590.txt   1154343
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 081166728
SIC: 2834 Pharmaceutical Preparations